Follow On Project - Digitalising Pharmacy Services

后续项目 - 数字化药房服务

• 批准号: 830204
• 金额: $ 114.04万
• 依托单位: TITAN PMR LTD
• 依托单位国家: 英国
• 项目类别: Innovation Loans
• 财政年份: 2021
• 资助国家: 英国
• 起止时间: 2021 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=830204
• 关键词: Follow; Project; Digitalising; Pharmacy; Services

We are a Bristol based health-tech company that has developed a technology solution for the pharmacy market. Our product, Titan, transforms the way prescriptions are dispensed, introduces efficiencies and creates a new digital platform for the future of pharmacy.The Company was awarded an Innovate loan in February 2018 for the development of its system. The Company has successfully delivered and completed all of its project milestones including the approval of Titan by NHS Digital for Electronic Prescription Service in August 2019, making it the first new pharmacy system (known as a PMR) for the sector in over 15 years.Titan has now been implemented into 70 'Trailblazer' community pharmacies across England and Wales. Our product has also attracted the attention of large corporates looking for a strong platform to enable their growth. Our Enterprise model has been successfully implemented into Echo Pharmacy, the fastest growing pharmacy in the UK, and MWI, the largest veterinary supplier. Titan is now processing over 1 million prescriptions per month which represents around 1% of all prescriptions dispensed in England and Wales.Whilst Titan continues to attract progressive businesses, the ongoing pandemic has affected our ability to penetrate the core independent community pharmacy sector. The priorities for most high street pharmacies have shifted due to Covid-19 and so are now demanding solutions that support their immediate challenges.With additional support from Innovate UK we plan to develop a wide range of new game-changing Apps, delivered as extensions on the Titan platform. The new Apps will help address the immediate challenges that pharmacies are facing as a result of Covid-19 and provide innovative solutions to support their businesses and their patients in the long term.The benefits of our new innovations will not only help pharmacies survive through these difficult times but also help ensure the continuity of medicines supplies in the UK. Crucially, this Follow On project will help Titan exceed its original market penetration as it becomes an attractive product for pharmacy chains as well as independents.

我们是一家总部位于布里斯托的健康科技公司，为制药市场开发了一种技术解决方案。我们的产品Titan改变了处方配药的方式，提高了效率，并为药房的未来创造了一个新的数字平台。该公司于2018年2月获得了创新贷款，用于开发其系统。该公司已成功交付并完成了其所有项目里程碑，包括2019年8月NHS Digital批准Titan用于电子处方服务，使其成为该行业15年来的第一个新药房系统（称为PMR）。Titan现已在英格兰和威尔士的70个“开拓者”社区药房中实施。我们的产品也吸引了大型企业的关注，他们正在寻找一个强大的平台来实现他们的增长。我们的企业模式已成功地应用于英国发展最快的药房Echo Pharmacy和最大的兽医供应商MWI。Titan现时每月处理超过100万张处方，约占英格兰及威尔士所有处方的1%。虽然Titan继续吸引先进的业务，但持续的疫情影响了我们渗透核心独立社区药房行业的能力。由于新冠肺炎疫情，大多数商业街药店的优先事项已经发生了变化，因此现在需要解决方案来应对他们眼前的挑战。在Innovate UK的额外支持下，我们计划开发一系列新的改变游戏规则的应用程序，作为Titan平台的扩展提供。新的应用程序将有助于解决药店因Covid-19而面临的直接挑战，并提供创新的解决方案来长期支持其业务和患者。我们的新创新的好处不仅将帮助药店度过这些困难时期，还有助于确保英国药品供应的连续性。至关重要的是，这个后续项目将帮助泰坦超过其原来的市场渗透，因为它成为一个有吸引力的产品，药房连锁店以及独立。